Effect of Telmisartan and Amlodipine on Home Blood Pressure by Monitoring Newly Developed Telemedicine System: Monitoring Test by Using Telemedicine. Telmisartan's Effect on Home Blood Pressure (TelTelbosu)

Nakamoto, Hidetomo; Nishida, Eiichi; Ryuzaki, Munekazu; Sone, Masayoshi; Suzuki, Hiromichi; Yoshimoto, Mitsuo; Itagaki, Kaoru

doi:10.1080/10641960701815804

Cited by 11 publications

(11 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…12, 37, 38, 40 The effects of different antihypertensive drug classes on the changes in clinic and home BP (using morning dosing) were evaluated for calcium channel blockers (6 studies), 12, 16, 17, 25, 35, 37 angiotensin converting enzyme inhibitors (5 studies), 13, 14, 18, 21, 22 and angiotensin II receptor blockers (7 studies). 18, 20-22, 24, 33, 41 Finally, we were able to compare the reductions of home BP with those of 24-hr BP in 7 articles 18, 20, 22, 25, 26, 32, 39 , and with daytime BP and nighttime BP in 5 articles. 22, 25, 26, 32, 39 …”

Section: Methodsmentioning

confidence: 99%

“…12-41 The full text of those papers identified as potentially relevant on the basis of their titles and abstracts was reviewed by 2 independent investigators (JI and DJC). The criteria for papers to be included in the present meta-analysis were as follows: (1) study evaluated the effect(s) of at least one antihypertensive drug therapy, (2) results published for both home BP and clinic BP, pre- and post-treatment, (3) home BP measured using a semiautomatic or automatic upper-arm cuff oscillometric device, and (4) home BP measured in the morning and/or evening according to the guidelines.…”

Section: Methodsmentioning

confidence: 99%

“…There were 13 articles in which home BP data were described separately for the morning and evening BP. 12-15, 18, 20, 23, 25, 30, 37, 38, 40, 41 We also evaluated the changes in clinic, morning, and evening BP depending on whether the antihypertensive medication was taken in the morning 12-15, 18, 20, 23, 25, 30, 41 or in the evening. 12, 37, 38, 40 The effects of different antihypertensive drug classes on the changes in clinic and home BP (using morning dosing) were evaluated for calcium channel blockers (6 studies), 12, 16, 17, 25, 35, 37 angiotensin converting enzyme inhibitors (5 studies), 13, 14, 18, 21, 22 and angiotensin II receptor blockers (7 studies).…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Changes in Home Versus Clinic Blood Pressure With Antihypertensive Treatments

et al. 2008

View full text Add to dashboard Cite

Home blood pressure (HBP) monitoring is recommended for assessing the effects of antihypertensive treatment, but it is not clear how the treatment-induced changes in HBP compare with the changes in clinic BP (CBP). We searched PubMed using the terms “home or self-measured blood pressure,” and selected articles in which the changes in CBP and HBP (using the upper arm oscillometric method) induced by antihypertensive drugs were presented. We performed a systematic review of 30 articles published before March 2008 that included a total of 6794 subjects. As there was significant heterogeneity in most of the outcomes, a random effects model was used for the meta-analyses. The mean changes (± standard error) in CBP and HBP (systolic/diastolic) were -15.2±0.03/-10.3±0.03 mmHg and -12.2±0.04/-8.0±0.04 mmHg respectively, although there were wide varieties of differences in the reduction between HBP and CBP. The reductions in CBP were correlated with those of HBP (systolic BP; r=0.66, B=0.48, diastolic BP; r=0.71, B=0.52, P<0.001). In 7 studies that also included 24-hour BP monitoring, the reduction of HBP was greater than that of 24-hr BP in systolic (HBP; -12.6±0.06 mmHg, 24-hr BP; -11.9±0.04 mmHg, P<0.001). In 5 studies that included daytime and nighttime systolic BP separately, HBP decreased 15% more than daytime ambulatory BP and 30% more than nighttime ambulatory BP. In conclusion, HBP falls about 20% less than CBP with antihypertensive treatments. Daytime systolic BP falls 15% less and nighttime systolic BP falls 30% less than home systolic BP.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Changes in Home Versus Clinic Blood Pressure With Antihypertensive Treatments

et al. 2008

View full text Add to dashboard Cite

show abstract

“…The beneficial effects of telmisartan on the 24-hour BP values consist not only of lowering the daytime and nighttime BP, but also effectively controlling BP variability [28,29] , which has been shown to be closely correlated with PWV [11] , target-organ damage [30] and the incidence of cardiovascular events and mortality independent of the absolute BP load [31] . Previous studies have shown that the inhibitory effects of telmisartan on BP variability were associated with a reduction in sympathetic nerve activity in hypertensive patients with overt nephropathy [28] .…”

Section: Discussionmentioning

confidence: 99%

Effects of Telmisartan on Arterial Stiffness Assessed by the Cardio-Ankle Vascular Index in Hypertensive Patients

Kinouchi¹,

Ichihara

Sakoda³

et al. 2010

Kidney Blood Press Res

View full text Add to dashboard Cite

Background/Aims: This study was conducted to determine the effect of telmisartan on the cardio-ankle vascular index (CAVI), a novel blood pressure (BP)-independent marker for arterial stiffness in hypertensive patients. Methods: One hundred consecutive hypertensive patients were randomly assigned either to a group treated with calcium channel blocker (CCB)-based therapy or a group treated with telmisartan-based therapy. Clinical and biological parameters were then measured before and 12 months after the start of this study. Results: CAVI, the logarithm of urinary albumin excretion, and BP were reduced significantly after telmisartan-based therapy. The decreases in 24-hour diastolic BP and daytime systolic BP associated with telmisartan-based therapy were significantly greater than those associated with CCB-based therapy. Both therapies significantly and similarly decreased the clinical BP, 24-hour systolic BP, daytime diastolic BP and serum levels of low-density lipoprotein cholesterol. No significant differences in the metabolic parameters were observed between the two therapies. Conclusion: Telmisartan-based therapy had beneficial effects on arterial stiffness assessed by CAVI, albuminuria, 24-hour BP and metabolism compared with CCB-based therapy. Since these markers are known to influence the future risk of cardiovascular events, telmisartan could be a useful drug for hypertensive patients.

show abstract

“…As a result, such data have been transmitted via telephone lines or the internet, and are widely used for decision making [61][62][63][64][65] and clinical pharmacological evaluations. 65,66 Improvements in BP control by means of such telemedicine have been reported. 61,64,[67][68][69][70][71] 4) HOME BP AND BP CONTROL The Japanese and International guidelines recognize home BP measurements as an optimal tool for long-term BP control.…”

Section: ) Home Bp and Prognosismentioning

confidence: 99%

The Japanese Society of Hypertension Guidelines for Self-monitoring of Blood Pressure at Home (Second Edition)

et al. 2012

View full text Add to dashboard Cite

INTRODUCTIONSince Riva-Rocci invented indirect brachial cuff sphygmomanometry in 1896 1 and Korotkoff proposed the auscultatory method in 1905, 2 the method for blood pressure (BP) measurements has remained essentially unchanged for the past 100 years.In 1969, Posey et al. 3 identified mean BP on the basis of the cuff-oscillometric method. With subsequent theoretical and technical improvements, the method to determine systolic and diastolic BP (S and D, respectively) was introduced to the cuff-oscillometric method. As a result, many of the automatic electronic sphygmomanometers available today have adopted this method, and those different from the auscultatory method have begun to be used in general clinical practice. Since the advent of indirect methods for sphygmomanometry, the past century has developed the practical and clinical sciences of hypertension. However, BP information necessary for the diagnosis and treatment of hypertension is still obtained essentially on the basis of casual measurements at the outpatient clinic (clinic BP). However, the reliability of clinic BP was called into question 40 years after the advent of indirect sphygmomanometry. In 1940, Ayman and Goldshine 4 widely adopted the concept of self-BP measurements in the field of clinic BP measurements and demonstrated discrepancies between clinic BP and self-BP measurements. Bevan, 5 in the United Kingdom, first reported the results of ambulatory BP (ABP) monitoring (ABPM) using a direct arterial BP measurement method in 1969, and showed that human BP changes markedly with time. The quantity and quality of BP information vary greatly according to different methods, and the problem of interpreting clinic BP, which is obtained specifically in a medical environment, has been an issue in the clinical practice of hypertension during the past 50 years.However, the practice and epidemiology of hypertension still depend entirely on BP information obtained in a medical environment (clinic BP/BP at a health examination), resulting in the

show abstract

Effect of Telmisartan and Amlodipine on Home Blood Pressure by Monitoring Newly Developed Telemedicine System: Monitoring Test by Using Telemedicine. Telmisartan's Effect on Home Blood Pressure (TelTelbosu)

Cited by 11 publications

References 12 publications

Changes in Home Versus Clinic Blood Pressure With Antihypertensive Treatments

Changes in Home Versus Clinic Blood Pressure With Antihypertensive Treatments

Effects of Telmisartan on Arterial Stiffness Assessed by the Cardio-Ankle Vascular Index in Hypertensive Patients

The Japanese Society of Hypertension Guidelines for Self-monitoring of Blood Pressure at Home (Second Edition)

Contact Info

Product

Resources

About